Pulsiv raises £1.5 million in equity funding round
Our portfolio company Pulsiv has raised £1.5 million to support further commercialisation of its ground-breaking, high-efficiency power conversion technology.
Read moreFinal results: portfolio equity value up 24 per cent to £39.7 million
A landmark year saw our first partial exit after Exscientia listed on Nasdaq and the rest of the portfolio performed strongly. Pre-tax profits rose to £10.9 million
Read morePulsiv unveils world-leading electronics technology to cut energy consumption
Our portfolio company Pulsiv has launched Pulsiv OSMIUM, a new technology to significantly improve the energy efficiency of power supplies and battery chargers.
Read moreSir Michael Rake to join CamGraPhIC board as company raises £1.26 million
Former BT Group chairman and CamGraPhIC investor will join board by the end of the year. The company has also raised £1.26 million to support scale up, of its graphene-based photonics technology.
Read moreCambridge Raman Imaging raises £1.1 million to accelerate scale up
Cambridge Raman Imaging is to use proceeds to further develop first commercial prototype of Raman imaging microscope and artificial intelligence to support disease diagnosis and treatment.
Read moreRobot-picked raspberries, COVID-19 vaccines, Portugal and graphene: read our newsletter
Robot-picked raspberries are now in the shops, thanks to Fieldwork Robotics, featured in our latest newsletter. There are also updates on TVG, Portugal and a look at graphene.
Read moreBeyond Venture Funding: join our event with Williams Advanced Engineering on 17 May
Frontier IP is teaming up with Williams Advanced Engineering to explore alternatives to traditional venture capital approaches to supporting early-stage technology companies. The online event is at 3.00pm on 17 May.
Read moreHalf year results: pre-tax profits rise by 239 per cent to £10.3 million
Highlights for the six months to December included the float of Exscientia for a value of $2.9 billion. After the period end, we sold 25 per cent of our stake for £6.1 million.
Read moreFrontier IP raises further £3.2 million after selling more Exscientia shares
Most recent sales takes total net proceeds raised from Exscientia holding to £6.1 million. Following the sales, we retain 1,173,600 shares in the company. Learn more from Chief Executive Neil Crabb’s interview with Proactive London
Read moreCambridge Raman Imaging gains grant to transform cancer diagnosis and treatment
Portfolio company is coordinating CHARM, a pan-European project set to receive €3.3 million to develop low-cost, high-speed medical imaging technology for cancer diagnosis and treatment.
Read more